Stephen Worthley

Stephen Worthley

Interventional cardiologist / Cardiologist
GenesisHeartCare - Sydney, Australia

Latest contributions

Device-based interventional therapies for hypertension – Part I – Carotid neuromodulation

18 May 2017 – From EuroPCR 2017

Consult this session on Device-based interventional therapies for hypertension – Part I: Carotid neuromodulation, if you want to discover more about neuromodulation and appreciate the different device features, procedural steps and clinical study results.With the collaboration of the Practical Course on Hypertension (PCH)

Transcatheter annular reduction therapy (TART) for functional mitral regurgitation: an introduction to the ARTO System

17 May 2017 – From EuroPCR 2017

Self-expanding TAVI technology - How to safeguard simplicity, safety and effectiveness?

16 May 2017 – From EuroPCR 2017

Innovation in aortic and mitral valve interventions

16 May 2017 – From EuroPCR 2017

A clinical look at novel DES technologies

16 May 2017 – From EuroPCR 2017

TAVI in contemporary practice - part 2

19 May 2016 – From EuroPCR 2016

Lars Sondergaard

Chairperson

Lars Sondergaard

Portico transcatheter aortic valve: when novel technology drives optimal clinical outcomes

18 May 2016 – From EuroPCR 2016

Stephen Worthley

Chairperson

Stephen Worthley

What's new in hypertension? An update for interventionists

17 May 2016 – From EuroPCR 2016

Mid- and long-term outcome after renal denervation

17 May 2016 – From EuroPCR 2016

Chairperson

Faisal Sharif

TAVI advancements: key learnings and perspectives of the Portico valve programme

20 May 2015 – From EuroPCR 2015

Stephen Worthley

Chairperson

Stephen Worthley

Away from the spotlights - Subset data insights in resistant hypertension

22 May 2014 – From EuroPCR 2014

Sebastian Ewen

Chairperson

Sebastian Ewen
Dr. Soo Teik Lim

Chairperson

Soo Teik Lim

Moderated abstract corner

22 May 2014 – From EuroPCR 2014

Renal denervation: addressing the challenge of evolving from building foundational clinical evidence to establishing a daily practice in renal denervation

21 May 2014 – From EuroPCR 2014

Chairperson

Michael Böhm
Melvin David Lobo

Chairperson

Melvin David Lobo

Can an in-situ recapturable and repositionable TAVI platform influence procedural and patient outcome

21 May 2014 – From EuroPCR 2014

Ganesh Manoharan

Chairperson

Ganesh Manoharan

Moving forward in resistant hypertension - Study updates and results

21 May 2014 – From EuroPCR 2014

Roland Schmieder

Chairperson

Roland Schmieder
Konstantinos Tsioufis

Chairperson

Konstantinos Tsioufis

Renal denervation for resistant hypertension

24 May 2013 – From EuroPCR 2013

Stephen Worthley

Chairperson

Stephen Worthley

Chairperson

Yangsoo Jang

Clinical update on EnligHTN, the original multi-electrode catheter-based renal sympathetic denervation system

23 May 2013 – From EuroPCR 2013

Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher

Chairperson

Michael Böhm

Overcoming TAVI challenges

21 May 2013 – From EuroPCR 2013

Mohammed Balghith

Chairperson

Mohammed Balghith
Georges Ghanem

Chairperson

Georges Ghanem
Stephen Worthley

Chairperson

Stephen Worthley